3[3]D'Amour P,Brossard JH,Rakel A,et al.Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19[J].Clin Chem,2005,51(1):169-176.
4[4]Goodman WG.The evolution of assays for parathyroid hormone[J].Semin Dial,2005,18(4):296-301.
5[5]Ljungdahl N,Haarhaus M,Linder C,et al.Comparison of 3 third-generation assays for bio-intact parathyroid hormone[J].Clin Chem,2006,52(5):903-904.
6[6]Souberbielle JC,Friedlander G,Cormier C.Practical considerations in PTH testing[J].Clin Chim Acta,2006,366(1-2):81-89.
7[7]Souberbielle JC,Boutten A,Carlier MC,et al.Intermethod variability in PTH measurement:implication for the care of CKD patients[J].Kidney Int,2006,70(2):345-350.
8[8]National Kidney Foundation.K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease[J].Am J Kidney Dis,2003,42(4 suppl 3):s1-s201.
9[9]Martin KJ,Olgaard K,Coburn JW,et al.Diagnosis,assessment,and treatment of bone turnover abnormalities in renal osteodystrophy[J].Am J Kidney Dis,2004,43(3):558-565.
10[10]Tokumoto A.Case study of patient with adynamie low bone turnover disease that eluded diagnosis-comparison of PTH ratio with other markers of bone turnover[J].J Am Soc Nephrol,2003,14:902A.
